Filippo Acconcia

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 21

Top Topics

Breast Cancer Cells

Endoplasmic Reticulum

Estrogen Receptor

Top Venues

International journal of molecular sciences

Journal of cellular biochemistry

Cellular oncology (Dordrecht)

This page only lists publications with an associated author ORCID identifier.

Publications

Marco Fiocchetti, Serena Raimondi, Giovanna Bastari, Stefania Bartoloni, Maria Marino, Filippo Acconcia
Characterization of ERα Signaling to Cell Proliferation Induced by Chronic and Pulsatile E2 Stimulation in 2D and 3D Cell Cultures. Journal of cellular biochemistry (2024)
Marco Fiocchetti, Serena Raimondi, Giovanna Bastari, Stefania Bartoloni, Maria Marino, Filippo Acconcia
Characterization of ERα Signaling to Cell Proliferation Induced by Chronic and Pulsatile E2 Stimulation in 2D and 3D Cell Cultures. Journal of cellular biochemistry 125 (7) (2024)
Marco Fiocchetti, Serena Raimondi, Giovanna Bastari, Stefania Bartoloni, Maria Marino, Filippo Acconcia
Characterization of ERα Signaling to Cell Proliferation Induced by Chronic and Pulsatile E2 Stimulation in 2D and 3D Cell Cultures. Journal of cellular biochemistry 125 (7) (2024)
Emiliano Montalesi, Patrizio Cracco, Filippo Acconcia, Marco Fiocchetti, Giovanna Iucci, Chiara Battocchio, Elisabetta Orlandini, Lidia Ciccone, Susanna Nencetti, Maurizio Muzzi, Sandra Moreno, Andrea Bearzotti, Maria Marino
Resveratrol Analogs and Prodrugs Differently Affect the Survival of Breast Cancer Cells Impairing Estrogen/Estrogen Receptor α/Neuroglobin Pathway. International journal of molecular sciences 24 (3) (2023)
Emiliano Montalesi, Patrizio Cracco, Filippo Acconcia, Marco Fiocchetti, Giovanna Iucci, Chiara Battocchio, Elisabetta Orlandini, Lidia Ciccone, Susanna Nencetti, Maurizio Muzzi, Sandra Moreno, Andrea Bearzotti, Maria Marino
Resveratrol Analogs and Prodrugs Differently Affect the Survival of Breast Cancer Cells Impairing Estrogen/Estrogen Receptor α/Neuroglobin Pathway. International journal of molecular sciences 24 (3) (2023)
Emiliano Montalesi, Patrizio Cracco, Filippo Acconcia, Marco Fiocchetti, Giovanna Iucci, Chiara Battocchio, Elisabetta Orlandini, Lidia Ciccone, Susanna Nencetti, Maurizio Muzzi, Sandra Moreno, Andrea Bearzotti, Maria Marino
Resveratrol Analogs and Prodrugs Differently Affect the Survival of Breast Cancer Cells Impairing Estrogen/Estrogen Receptor α/Neuroglobin Pathway. International journal of molecular sciences 24 (3) (2023)
Filippo Acconcia
Evaluation of the Sensitivity of Breast Cancer Cell Lines to Cardiac Glycosides Unveils ATP1B3 as a Possible Biomarker for the Personalized Treatment of ERα Expressing Breast Cancers. International journal of molecular sciences 23 (19) (2022)
Valentina Pallottini, Marco Segatto, Filippo Acconcia, Marco Fiocchetti, Maria Marino
Mechanism Underlying Naringenin Hypocholesterolemic Effects: Involvement of Estrogen Receptor α Subtype. International journal of molecular sciences 23 (24) (2022)
Valentina Pallottini, Marco Segatto, Filippo Acconcia, Marco Fiocchetti, Maria Marino
Mechanism Underlying Naringenin Hypocholesterolemic Effects: Involvement of Estrogen Receptor α Subtype. International journal of molecular sciences 23 (24) (2022)
Filippo Acconcia
Editorial for the Special Issue "New Drugs for Breast Cancer Treatment". International journal of molecular sciences 23 (18) (2022)
Valentina Pallottini, Marco Segatto, Filippo Acconcia, Marco Fiocchetti, Maria Marino
Mechanism Underlying Naringenin Hypocholesterolemic Effects: Involvement of Estrogen Receptor α Subtype. International journal of molecular sciences 23 (24) (2022)
Stefania Bartoloni, Stefano Leone, Sara Pescatori, Manuela Cipolletti, Filippo Acconcia
The antiviral drug telaprevir induces cell death by reducing FOXA1 expression in estrogen receptor α (ERα)-positive breast cancer cells. Molecular oncology 16 (19) (2022)
Sara Pescatori, Stefano Leone, Manuela Cipolletti, Stefania Bartoloni, Alessandra di Masi, Filippo Acconcia
Clinically relevant CHK1 inhibitors abrogate wild-type and Y537S mutant ERα expression and proliferation in luminal primary and metastatic breast cancer cells. Journal of experimental & clinical cancer research : CR 41 (1) (2022)
Marco Fiocchetti, Giovanna Bastari, Manuela Cipolletti, Stefano Leone, Filippo Acconcia, Maria Marino
The Peculiar Estrogenicity of Diethyl Phthalate: Modulation of Estrogen Receptor α Activities in the Proliferation of Breast Cancer Cells. Toxics 9 (10) (2021)
Sara Pescatori, Francesco Berardinelli, Jacopo Albanesi, Paolo Ascenzi, Maria Marino, Antonio Antoccia, Alessandra di Masi, Filippo Acconcia
A Tale of Ice and Fire: The Dual Role for 17β-Estradiol in Balancing DNA Damage and Genome Integrity. Cancers 13 (7) (2021)
Manuela Cipolletti, Stefania Bartoloni, Claudia Busonero, Martina Parente, Stefano Leone, Filippo Acconcia
A New Anti-Estrogen Discovery Platform Identifies FDA-Approved Imidazole Anti-Fungal Drugs as Bioactive Compounds against ERα Expressing Breast Cancer Cells. International journal of molecular sciences 22 (6) (2021)
Claudia Busonero, Stefano Leone, Fabrizio Bianchi, Elena Maspero, Marco Fiocchetti, Orazio Palumbo, Manuela Cipolletti, Stefania Bartoloni, Filippo Acconcia
Ouabain and Digoxin Activate the Proteasome and the Degradation of the ERα in Cells Modeling Primary and Metastatic Breast Cancer. Cancers 12 (12) (2020)
Manuela Cipolletti, Stefano Leone, Stefania Bartoloni, Claudia Busonero, Filippo Acconcia
Real-time measurement of E2: ERα transcriptional activity in living cells. Journal of cellular physiology 235 (10) (2020)
Claudia Busonero, Stefano Leone, Fabrizio Bianchi, Filippo Acconcia
In silico screening for ERα down modulators identifies thioridazine as an anti-proliferative agent in primary, 4OH-tamoxifen-resistant and Y537S ERα-expressing breast cancer cells. Cellular oncology (Dordrecht) 41 (6) (2018)
Stefano Leone, Claudia Busonero, Filippo Acconcia
A high throughput method to study the physiology of E2:ERα signaling in breast cancer cells. Journal of cellular physiology 233 (5) (2017)
Claudia Busonero, Stefano Leone, Filippo Acconcia
Emetine induces estrogen receptor alpha degradation and prevents 17β-estradiol-induced breast cancer cell proliferation. Cellular oncology (Dordrecht) 40 (3) (2017)